153 related articles for article (PubMed ID: 34697179)
1. Comparison of Three Assays for Total and Free PSA Using Hybritech and WHO Calibrations.
Garrido MM; Marta JC; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
In Vivo; 2021; 35(6):3431-3439. PubMed ID: 34697179
[TBL] [Abstract][Full Text] [Related]
2. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards.
Stephan C; Kahrs AM; Klotzek S; Reiche J; Müller C; Lein M; Deger S; Miller K; Jung K
Clin Chem Lab Med; 2008; 46(5):623-9. PubMed ID: 18839463
[TBL] [Abstract][Full Text] [Related]
3. Standardization of PSA measures: a reappraisal and an experience with WHO calibration of Beckman Coulter Access Hybritech total and free PSA.
Vignati G; Giovanelli L
Int J Biol Markers; 2007; 22(4):295-301. PubMed ID: 18161661
[TBL] [Abstract][Full Text] [Related]
4. Consistency and diagnostic accuracy of 4 assays in the detection of the total and free prostate-specific antigen.
Deng L; Yue D; Wang X; Li H
Transl Androl Urol; 2023 Feb; 12(2):261-270. PubMed ID: 36915871
[TBL] [Abstract][Full Text] [Related]
5. The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers.
Garrido MM; Ribeiro R; Pinheiro LC; Holdenrieder S; Guimarães JT
Clin Chem Lab Med; 2021 Oct; 59(11):1869-1877. PubMed ID: 34318651
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays.
Fillée C; Tombal B; Philippe M
Clin Chem Lab Med; 2010 Feb; 48(2):285-8. PubMed ID: 20001849
[TBL] [Abstract][Full Text] [Related]
7. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.
Stephan C; Klaas M; Müller C; Schnorr D; Loening SA; Jung K
Clin Chem; 2006 Jan; 52(1):59-64. PubMed ID: 16391327
[TBL] [Abstract][Full Text] [Related]
8. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA.
Slev PR; La'ulu SL; Roberts WL
Am J Clin Pathol; 2008 Jun; 129(6):952-8. PubMed ID: 18480013
[TBL] [Abstract][Full Text] [Related]
9. Discordant prostate specific antigen test results despite WHO assay standardization.
Boegemann M; Arsov C; Hadaschik B; Herkommer K; Imkamp F; Nofer JR; Gerß J; Albers P; Semjonow A
Int J Biol Markers; 2018 Aug; 33(3):275-282. PubMed ID: 29734838
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation.
Kort SA; Martens F; Vanpoucke H; van Duijnhoven HL; Blankenstein MA
Clin Chem; 2006 Aug; 52(8):1568-74. PubMed ID: 16762996
[TBL] [Abstract][Full Text] [Related]
11. 20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centers.
Stephan C; Bangma C; Vignati G; Bartsch G; Lein M; Jung K; Philippe M; Semjonow A; Catalona WJ
Int J Biol Markers; 2009; 24(2):65-9. PubMed ID: 19634108
[TBL] [Abstract][Full Text] [Related]
12. Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays.
de la Taille A; Houlgatte A; Houdelette P; Goluboff ET; Berlizot P; Ricordel I
Br J Urol; 1998 Sep; 82(3):389-92. PubMed ID: 9772876
[TBL] [Abstract][Full Text] [Related]
13. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
Stephan C; Köpke T; Semjonow A; Lein M; Deger S; Schrader M; Miller K; Jung K
Clin Chem Lab Med; 2009; 47(11):1325-31. PubMed ID: 19778292
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of new prostate-specific antigen WHO standardization on biopsy rates and cancer detection.
Jansen FH; Roobol M; Bangma CH; van Schaik RH
Clin Chem; 2008 Dec; 54(12):1999-2006. PubMed ID: 18927249
[TBL] [Abstract][Full Text] [Related]
15. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management.
Ferraro S; Biganzoli G; Bussetti M; Castaldi S; Biganzoli EM; Plebani M
Clin Chem Lab Med; 2023 Jan; 61(1):142-153. PubMed ID: 36322977
[TBL] [Abstract][Full Text] [Related]
16. Variability of assay methods for total and free PSA after WHO standardization.
Foj L; Filella X; Alcover J; Augé JM; Escudero JM; Molina R
Tumour Biol; 2014 Mar; 35(3):1867-73. PubMed ID: 24092573
[TBL] [Abstract][Full Text] [Related]
17. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays.
Kaufmann B; Pellegrino P; Zuluaga L; Ben-David R; Müntener M; Keller EX; Spanaus K; von Eckardstein A; Gorin MA; Poyet C
Eur Urol Open Sci; 2024 May; 63():4-12. PubMed ID: 38558765
[TBL] [Abstract][Full Text] [Related]
18. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
19. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
[TBL] [Abstract][Full Text] [Related]
20. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.
Stephan C; Cammann H; Meyer HA; Müller C; Deger S; Lein M; Jung K
BJU Int; 2008 Sep; 102(7):799-805. PubMed ID: 18522632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
